Radiopharm Theranostics Limited (RADX)

Radiopharm Theranostics Revenue

In the fiscal year ending June 30, 2026, Radiopharm Theranostics had annual revenue of 12.87M AUD, down -1.05%. Radiopharm Theranostics had revenue of 6.66M in the half year ending June 30, 2026.

• Revenue (ttm): 12.87M AUD
• Revenue Growth: -1.05%
• P/S Ratio: 1.37
• Revenue / Employee: 918,938 AUD
• Employees: 14
• Market Cap: 12.79M USD

Revenue Chart

Chart

Chart

* This company reports financials in AUD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2026	12.87M	-136.84K	-1.05%
Jun 30, 2025	13.00M	11.41M	716.81%
Jun 30, 2024	1.59M	-4.62M	-74.37%
Jun 30, 2023	6.21M	-	-
Jun 30, 2022	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 28, 2026

Data Sources Report a data error